Loading...
Zovirax
Antiviral • Nucleoside analog
Selectively phosphorylated by viral thymidine kinase, then inhibits viral DNA polymerase
Drug Class
Antiviral
Subclass
Nucleoside analog
Half-life
2.5-3.3 hours
Time for plasma concentration to decrease by 50%
Protein Binding
9-33%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses